
Octiross 100mg Injection
Marketer
Vostro Critical Care
Salt Composition
Octreotide acetate (100mg)
Overview Octiross 100mg Injection
Octiross 100mg Injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, also preventing post-pancreatic surgery complications. Administration is exclusively by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal therapeutic effect; discontinuation should only occur under medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and all other medications currently being used.
Uses of Octiross 100mg Injection
Overgrowth of the extremities, carcinoid neoplasms, and hemorrhaging esophageal varices.
Major Benefits of Octiross 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Octiross 100mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Octiross 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Octiross 100mg Injection works:
Octiross 100mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication reduces the activity of various hormones, including growth hormone, and diminishes esophageal bleeding by vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Octiross 100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Octiross 100mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Octiross 100mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Octiross 100mg Injection.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Octiross 100mg Injection poses no safety concerns. No dosage modification is advised for Octiross 100mg Injection in this patient population.
LiverCAUTION
Patients with hepatic impairment should use Octiross 100mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Octiross 100mg Injection :
Should you forget a dose of Octiross 100mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Octiross 100mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin Analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Behavior Class | Somatostatin receptor ligands |
